Minimal residual disease (MRD) assessment by multiparametric flow cytometry is prognostic for progression-free survival in Phase 1/1b relapsed/refractory acute myeloid leukemia …
user-5f8411ab4c775e9685ff56d3（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要